New Trials Recently Added to BCT and MTS (January 2019)
- ADCT-301 in Patients With Advanced Triple Negative Breast Cancer
- Anetumab Ravtansine in Advanced Triple Negative Tumors That Are Mesothelin-Positive
- A Vaccine-Based Immunotherapy For Stage IV Triple Negative Breast Cancer
- Durvalumab & Olaparib in Advanced Triple Negative Breast Cancer Treated with Chemotherapy
- LAG525 plus Spartalizumab or Carboplatin in Advanced Triple-Negative Breast Cancer
- Tavo and Pembrolizumab (Immunotherapy) in Advanced Triple Negative Tumors
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.